Production and characterization of Clostridium perfringens recombinant β toxoid. 2012

Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
Centro de Desenvolvimento Tecnológico - Biotecnologia, Universidade Federal de Pelotas, RS, Brazil.

In this work, we produced and evaluated a vaccine based on a β toxoid of Clostridium perfringens type C produced in Escherichia coli (rBT). The non-toxic rBT was innocuous for mice and induced 14 IU mL(-1) of β antitoxin in rabbits, complying with the European Pharmacopeia and CFR9 - USDA guidelines.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003016 Clostridium perfringens The most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins. Clostridium welchii
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D014121 Toxoids Preparations of pathogenic organisms or their derivatives made nontoxic and intended for active immunologic prophylaxis. They include deactivated toxins. Anatoxin toxoids are distinct from anatoxins that are TROPANES found in CYANOBACTERIA. Anatoxin Toxoid,Toxins, Deactivated,Toxoid,Anatoxin Toxoids,Deactivated Toxins,Toxoid, Anatoxin,Toxoids, Anatoxin
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014614 Vaccines, Synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens, Synthetic,Chemical Vaccine,Chemical Vaccines,Immunogens, Synthetic,Molecular Vaccine,Molecular Vaccines,Recombinant Vaccine,Semisynthetic Vaccine,Semisynthetic Vaccines,Synthetic Antigen,Synthetic Vaccine,Synthetic Vaccines,Vaccines, Recombinant,Synthetic Antigens,Synthetic Immunogens,Vaccines, Chemical,Vaccines, Molecular,Vaccines, Semisynthetic,Antigen, Synthetic,Recombinant Vaccines,Vaccine, Chemical,Vaccine, Molecular,Vaccine, Recombinant,Vaccine, Semisynthetic,Vaccine, Synthetic

Related Publications

Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
December 2017, Research in veterinary science,
Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
February 1970, Japanese journal of medical science & biology,
Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
January 1998, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
June 1962, Journal of bacteriology,
Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
August 2010, Vaccine,
Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
February 1972, Japanese journal of medical science & biology,
Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
January 1982, Giornale di batteriologia, virologia ed immunologia,
Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
January 2007, Journal of biotechnology,
Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
April 1970, Japanese journal of medical science & biology,
Adalgisa Milach, and João Rodrigo Gil de los Santos, and Carlos Gil Turnes, and Angela Nunes Moreira, and Ronnie Antunes de Assis, and Felipe Masiero Salvarani, and Francisco Carlos Faria Lobato, and Fabricio Rochedo Conceição
April 1986, Infection and immunity,
Copied contents to your clipboard!